RapidVector™ Services
Source: MilliporeSigma
A fast, low risk path to evaluating vector performance before committing to large-scale manufacturing.
Validate your concept quickly without a large upfront investment
Our RapidVectorTM Services provide small-scale AAV and LV material to help you generate the data needed to advance to your next development milestone.
- Bench-scale, proof-of-concept batch for construct feasibility studies: Fast access to the research-grade material and data you need to drive investor confidence and advance partnership opportunities in less than 8 weeks*.
- Small-scale preclinical batch for IND-enabling studies: Cost-effective insight into performance, yield, and quality in less than 12 weeks*—using our GMP-aligned platform processes that de-risk scale-up and produce strong, decision-ready data.

Delivering value, efficiency, and confidence to advance your program forward
- Cost-Effective
- Fast timelines
- Standardized workflows
- Robust analytics
* Timeline is subject to terms and conditions. Timelines do not include GOI plasmid production.
Ready to bridge early insights into clinical readiness?